Panel Discussion on Cell Therapy GMP Manufacturing
Join us as we discuss some of the common issues and latest innovations around GMP manufacturing for cell therapy applications.
- Pam Contag, Ph.D., CEO, Bioeclipse
- Everett Meyers, MD, Ph.D., Medical and Scientific Director, Cellular Therapy Facility at Stanford University
- Andy Kogelnik, MD, Ph.D., Director, Open Medicine Institute
- Hua Tu, Ph.D., CEO, LakePharma